春立医疗
(688236)
| 流通市值：65.99亿 | | | 总市值：87.76亿 |
| 流通股本：2.88亿 | | | 总股本：3.84亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 487,596,405.66 | 229,843,941.53 | 805,857,022.19 | 508,283,661.62 |
| 营业收入 | 487,596,405.66 | 229,843,941.53 | 805,857,022.19 | 508,283,661.62 |
| 二、营业总成本 | 333,777,775.81 | 163,972,970.3 | 678,243,060.18 | 449,469,327.29 |
| 营业成本 | 160,472,617.89 | 76,572,465.53 | 268,952,851.12 | 156,043,170.05 |
| 税金及附加 | 4,531,943.83 | 1,960,604.51 | 7,723,578.58 | 6,012,961.59 |
| 销售费用 | 96,267,759.62 | 46,121,370.37 | 240,247,102.81 | 163,464,944.14 |
| 管理费用 | 28,394,457.44 | 16,587,602.35 | 45,290,473.71 | 31,357,332.9 |
| 研发费用 | 50,854,271.53 | 26,897,460.32 | 133,096,848.59 | 99,676,406.7 |
| 财务费用 | -6,743,274.5 | -4,166,532.78 | -17,067,794.63 | -7,085,488.09 |
| 其中:利息费用 | 12,292.7 | - | 44,939.07 | 27,847.25 |
| 其中:利息收入 | 7,674,348.71 | 4,176,613.37 | 16,309,711.03 | 8,960,596.25 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 4,296,252.04 | 1,604,306.84 | 9,434,830.14 | 6,079,575.33 |
| 加:投资收益 | 3,217,026.86 | 3,217,026.86 | 10,980,482.17 | 9,122,896.79 |
| 资产处置收益 | 3,848.03 | -15,716.81 | 39,213.61 | 39,213.61 |
| 资产减值损失(新) | -26,911,765.98 | -790,286.65 | -33,776,793.41 | -9,409,707.93 |
| 信用减值损失(新) | -12,418,491.12 | -7,583,337.28 | -4,186,610.52 | -7,060,926.86 |
| 其他收益 | 5,307,719.73 | 2,183,975.41 | 20,609,609.96 | 7,865,268.9 |
| 四、营业利润 | 127,313,219.41 | 64,486,939.6 | 130,714,693.96 | 65,450,654.17 |
| 加:营业外收入 | 0.84 | 0.04 | 987,389.36 | 870,286.2 |
| 减:营业外支出 | 700 | - | 102,914.25 | 156,306.21 |
| 五、利润总额 | 127,312,520.25 | 64,486,939.64 | 131,599,169.07 | 66,164,634.16 |
| 减:所得税费用 | 12,831,365.21 | 6,456,361.94 | 6,937,885.57 | 5,155,985.69 |
| 六、净利润 | 114,481,155.04 | 58,030,577.7 | 124,661,283.5 | 61,008,648.47 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 114,481,155.04 | 58,030,577.7 | 124,661,283.5 | 61,008,648.47 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 114,469,490.87 | 58,071,117.89 | 124,988,009.59 | 61,151,445.55 |
| 少数股东损益 | 11,664.17 | -40,540.19 | -326,726.09 | -142,797.08 |
| 扣除非经常损益后的净利润 | 106,185,458.23 | 52,698,123.38 | 94,536,002.4 | 43,959,021.7 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.3 | 0.15 | 0.33 | 0.16 |
| (二)稀释每股收益 | 0.3 | 0.15 | 0.33 | 0.16 |
| 九、综合收益总额 | 114,481,155.04 | 58,030,577.7 | 124,661,283.5 | 61,008,648.47 |
| 归属于母公司股东的综合收益总额 | 114,469,490.87 | 58,071,117.89 | 124,988,009.59 | 61,151,445.55 |
| 归属于少数股东的综合收益总额 | 11,664.17 | -40,540.19 | -326,726.09 | -142,797.08 |
| 公告日期 | 2025-08-30 | 2025-04-30 | 2025-03-29 | 2024-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |